tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DE:4DN Stock Latest News

Denali Therapeutics price target lowered to $27 from $28 at BofA
The FlyDenali Therapeutics price target lowered to $27 from $28 at BofA
6d ago
DNLI
Denali Therapeutics price target lowered to $30 from $35 at B. Riley
PremiumThe Fly
Denali Therapeutics price target lowered to $30 from $35 at B. Riley
17d ago
DNLI
Denali Therapeutics price target lowered to $29 from $30 at Baird
PremiumThe Fly
Denali Therapeutics price target lowered to $29 from $30 at Baird
18d ago
DNLI
Denali Therapeutics: Promising Pipeline and Financial Stability Drive Buy Rating
PremiumRatings
Denali Therapeutics: Promising Pipeline and Financial Stability Drive Buy Rating
18d ago
DNLI
Denali Therapeutics Advances Pipeline Amid Financial Loss
PremiumCompany Announcements
Denali Therapeutics Advances Pipeline Amid Financial Loss
18d ago
DNLI
Denali Therapeutics price target lowered to $30 from $32 at Wedbush
PremiumThe FlyDenali Therapeutics price target lowered to $30 from $32 at Wedbush
18d ago
BIIB
DNLI
Denali Therapeutics price target lowered to $32 from $80 at H.C. Wainwright
Premium
The Fly
Denali Therapeutics price target lowered to $32 from $80 at H.C. Wainwright
18d ago
DNLI
Denali Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
Premium
Ratings
Denali Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
19d ago
DNLI
Denali Therapeutics reports Q1 EPS (78c), consensus (70c)
PremiumThe Fly
Denali Therapeutics reports Q1 EPS (78c), consensus (70c)
19d ago
DNLI
Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe Fly
Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
2M ago
DNLI
Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe Fly
Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
2M ago
DNLI
Denali Therapeutics Begins BLA Submission for Tividenofusp Alfa
PremiumCompany Announcements
Denali Therapeutics Begins BLA Submission for Tividenofusp Alfa
2M ago
8K
DNLI
Denali initiates BLA filing for accelerated approval of tividenofusp alfa
PremiumThe FlyDenali initiates BLA filing for accelerated approval of tividenofusp alfa
2M ago
DNLI
Denali Therapeutics price target lowered to $28 from $30 at BofA
Premium
The Fly
Denali Therapeutics price target lowered to $28 from $30 at BofA
3M ago
DNLI
Denali Therapeutics assumed with an Overweight at Morgan Stanley
Premium
The Fly
Denali Therapeutics assumed with an Overweight at Morgan Stanley
3M ago
DNLI
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
PremiumRatings
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
3M ago
DNLI
Denali Therapeutics Discontinues DNL343 ALS Trial
PremiumCompany Announcements
Denali Therapeutics Discontinues DNL343 ALS Trial
3M ago
8K
DNLI
Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G
PremiumThe Fly
Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G
3M ago
DNLI
Denali Therapeutics price target lowered to $35 from $38 at B. Riley
PremiumThe Fly
Denali Therapeutics price target lowered to $35 from $38 at B. Riley
3M ago
DNLI
Denali Therapeutics price target lowered to $42 from $50 at Oppenheimer
PremiumThe FlyDenali Therapeutics price target lowered to $42 from $50 at Oppenheimer
3M ago
DNLI
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
Premium
Ratings
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
3M ago
DNLI
Denali Therapeutics price target lowered to $32 from $33 at Wedbush
Premium
The Fly
Denali Therapeutics price target lowered to $32 from $33 at Wedbush
3M ago
DNLI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >